Abstract
Pempidine (1,2,2,6,6-pentamethylpiperidine) is a ganglion blocking agent introduced recently for the treatment of hypertension by oral administration of its hydrogen tartrate. It can be estimated colorimetrically by coupling with methyl orange, or fluorimetrically by reaction with eosin in xylene, the limits of sensitivity being 0.5 μg./ml. and 0.001 μg./ml. respectively. These methods, combined with appropriate extraction techniques, were suitable for estimating pempidine in aqueous solutions of its salts, in biological fluids and the like, and for investigating the biochemical properties of the drug when given orally to rats in amounts similar to those used clinically.
When administered orally to rats pempidine was rapidly absorbed, the maximum concentration in plasma being attained after 30 min. The drug was preferentially taken up by erythrocytes and a red cell/plasma partition ratio of about 1.2 established with clinical doses. Pempidine was soon distributed throughout the body, including the cerebrospinal fluid, and the highest concentrations were found in kidney, spleen and liver. Pempidine also entered the foetus and passed thence into the amniotic fluid. Protein-binding of the drug occurred only to a very limited extent and there was little evidence that it was metabolized. Pempidine was excreted rapidly in urine during 24 hr. following oral administration.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALLANBY K. D., TROUNCE J. R. Excretion of mecamylamine after intravenous and oral administration. Br Med J. 1957 Nov 23;2(5055):1219–1221. doi: 10.1136/bmj.2.5055.1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BAER J. E., BEYER K. H., PAULSON S. F., RUSSO H. F. Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine). Am J Physiol. 1956 Jul;186(1):180–186. doi: 10.1152/ajplegacy.1956.186.1.180. [DOI] [PubMed] [Google Scholar]
- BRODIE B. B., HOGBEN C. A. Some physico-chemical factors in drug action. J Pharm Pharmacol. 1957 Jun;9(6):345–380. doi: 10.1111/j.2042-7158.1957.tb12289.x. [DOI] [PubMed] [Google Scholar]
- CORNE S. J., EDGE N. D. Pharmacological properties of pempidine (1:2:2:6:6-pentamethylpiperidine), a new ganglion-blocking compound. Br J Pharmacol Chemother. 1958 Sep;13(3):339–349. doi: 10.1111/j.1476-5381.1958.tb00915.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HARINGTON M., KINCAID-SMITH P., MILNE M. D. Pharmacology and clinical use of pempidine in the treatment of hypertension. Lancet. 1958 Jul 5;2(7036):6–11. doi: 10.1016/s0140-6736(58)90002-3. [DOI] [PubMed] [Google Scholar]
- LEE G. E., WRAGG W. R., CORNE S. J., EDGE N. D., READING H. W. 1:2:2:6:6-Pentamethylpiperidine: a new hypotensive drug. Nature. 1958 Jun 21;181(4625):1717–1719. doi: 10.1038/1811717a0. [DOI] [PubMed] [Google Scholar]